Testing effectiveness (Phase 2)Study completedNCT02110225
What this trial is testing
A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)
Who this might be right for
Retinitis Pigmentosa
Dompé Farmaceutici S.p.A 50